Skip Navigation HRSA - Health Resources and Service Administration U.S. Department of Health & Human Services
Home
Questions
Order Publications
 
Grants Find Help Service Delivery Data Health System Concerns About HRSA

The HIV/AIDS Program: Ryan White Parts A - F

 

Part B - Grants To States and Territories


Fact Sheets

To order free copies of the 2008 Ryan White Grantee folder and fact sheets, call 1.888.ASK.HRSA or order online.

On this page...

   Eligibility      
   Funding      
   Providers      
   AIDS Drug Assistance Program      
 
Eligibilty

Part B of the Ryan White HIV/AIDS Treatment Modernization Act provides grants to all 50 States, the District of Columbia, Puerto Rico, Guam, the U.S. Virgin Islands, and 5 U.S. Pacific Territories or Associated Jurisdictions. Part B grants include a base grant, the AIDS Drug Assistance Program (ADAP) award, ADAP supplemental grants and grants to States for Emerging Communities—those reporting between 500 and 999 cumulative reported AIDS cases over the most recent 5 years. All funding is distributed via formula and other criteria.

Part B funds may be used to fund 75 percent of “core medical services” which include outpatient and ambulatory health services; ADAP; AIDS pharmaceutical assistance; oral health care; early intervention services; health insurance premium and cost-sharing assistance; home health care; medical nutrition therapy; hospice care; community-based health services; substance abuse outpatient care; and medical case management, including treatment adherence services.

The remaining 25 percent of funds must go to support services that are needed for people living with HIV/AIDS to achieve their medical outcomes, such as respite care, outreach services, medical transportation, linguistic services, and referrals for health care and support services.

TOP
Funding
In FY 2008, a total of $1.195 billion was appropriated to Part B programs, of which $808.5 million was “earmarked” for ADAP.

  • Base Part B grants are awarded to States and Territories using a formula based on reported living cases of HIV/AIDS. Also, States with more than 1 percent of total HIV/AIDS cases reported in the United States during the previous 2 years must provide matching funds with their own resources using a formula outlined in the legislation.
  • Additional Part B funds are earmarked for State ADAPs, which primarily provide medications. Fundable services also include treatment adherence and support as well as health insurance coverage with prescription drug benefits. Five percent of the ADAP earmark is reserved for grants to States and Territories that have a severe need for medication assistance. A new, supplemental, competitive program is now available to States and Territories based on demonstrated need criteria.
  • Part B provides $5.0 million in supplemental grants to States with Emerging Communities—cities with at least 500 but fewer than 1,000 reported AIDS cases in the most recent 5 years.

Part B provides a competitive grant of $7 million for the Minority AIDS Initiative, which provides education and outreach services to increase the number of eligible racial and ethnic minorities with access to treatment through the Part B ADAPs.

TOP
Providers

Part B providers may include both public and nonprofit entities. For-profit entities are eligible only if they are the sole providers of quality HIV care in the area. Most States provide some services directly, but other States work through subcontracts with Part B HIV Care Consortia. A care consortium is an association of public and nonprofit health care and support service providers and community-based organizations that plan, develop, and deliver services for people living with HIV disease. Services provided through a consortium are considered support services.

TOP
AIDS Drug Assistance Program
The AIDS Drug Assistance Program (ADAP) provides medications for the treatment of HIV disease. Program funds may also be used to purchase health insurance for eligible clients and for services that enhance access to, adherence to, and monitoring of drug treatments. The program is funded through Part B of the Ryan White HIV/AIDS Treatment Modernization Act (formerly known as the Ryan White Comprehensive AIDS Resources Emergency (CARE) Act) which provides grants to States and Territories. View ADAP Fact Sheet.